Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK–induced cancer cell plasticity
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci166847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Sanam Peyvandi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, Department of Oncology, Microbiology and Immunology (OMI), Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzer…. Hauptthemen laut MEDLINE: Breast Neoplasms, Lung Neoplasms, Neoplasms, Second Primary, Spinocerebellar Ataxias. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Swiss Cancer League, Medic Foundation.
Abstract (Originalsprache)
Cancer cell plasticity contributes to therapy resistance and metastasis, which represent the main causes of cancer-related death, including in breast cancer. The tumor microenvironment drives cancer cell plasticity and metastasis, and unraveling the underlying cues may provide novel strategies for managing metastatic disease. Using breast cancer experimental models and transcriptomic analyses, we show that stem cell antigen-1 positive (SCA1 + ) murine breast cancer cells enriched during tumor progression and metastasis had higher in vitro cancer stem cell–like properties, enhanced in vivo metastatic ability, and generated tumors rich in Gr1 hi Ly6G + CD11b + cells. In turn, tumor-educated Gr1 + CD11b + (Tu-Gr1 + CD11b + ) cells rapidly and transiently converted low metastatic SCA1 – cells into highly metastatic SCA1 + cells via secreted oncostatin M (OSM) and IL-6. JAK inhibition prevented OSM/IL-6–induced SCA1 + population enrichment, while OSM/IL-6 depletion suppressed Tu-Gr1 + CD11b + –induced SCA1 + population enrichment in vitro and metastasis in vivo. Moreover, chemotherapy-selected highly metastatic 4T1 cells maintained high SCA1 + positivity through autocrine IL-6 production, and in vitro JAK inhibition blunted SCA1 positivity and metastatic capacity. Importantly, Tu-Gr1 + CD11b + cells invoked a gene signature in tumor cells predicting shorter overall survival (OS), relapse-free survival (RFS), and lung metastasis in breast cancer patients. Collectively, our data identified OSM/IL-6/JAK as a clinically relevant paracrine/autocrine axis instigating breast cancer cell plasticity and triggering metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, Department of Oncology, Microbiology and Immunology (OMI), Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
- Translational Data Science Group, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
- Cell and Tissue Dynamics Research Program, Institute of Biotechnology, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Förderung
- Swiss National Science Foundation
- Swiss Cancer League
- Medic Foundation
Zitieren
APA
Peyvandi, S., Bulliard, M., Yilmaz, A., Kauzlaric, A., Marcone, R., Haerri, L., Coquoz, O., Huang, Y. T., Duffey, N., Gafner, L., Lorusso, G., Fournier, N., Lan, Q., & Rüegg, C. (2024). Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK–induced cancer cell plasticity. Journal of Clinical Investigation. https://doi.org/10.1172/jci166847
Vancouver
Peyvandi S, Bulliard M, Yilmaz A, Kauzlaric A, Marcone R, Haerri L, et al. Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK–induced cancer cell plasticity. Journal of Clinical Investigation. 2024. doi:10.1172/jci166847
BibTeX
@article{Peyvandi2024,
author = {Peyvandi, Sanam and Bulliard, Manon and Yilmaz, Alev and Kauzlaric, Annamaria and Marcone, Rachel and Haerri, Lisa and Coquoz, Oriana and Huang, Yu-Ting and Duffey, Nathalie and Gafner, Laetitia and Lorusso, Girieca and Fournier, Nadine and Lan, Qiang and Rüegg, Curzio},
title = {Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK–induced cancer cell plasticity},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci166847}
}
EUVIMED